Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acumen Pharmaceuticals | ABOS | Nov 15, 2024 | 2.40 | -8.05 |
Acurx Pharmaceuticals | ACXP | Nov 15, 2024 | 1.72 | -2.82 |
Acushnet | GOLF | Nov 15, 2024 | 69.31 | +1.54 |
ACV Auctions A | ACVA | Nov 15, 2024 | 20.72 | +3.50 |
ACWI Ex-US Index MSCI Ishares | ACWX | Nov 15, 2024 | 53.35 | -0.17 |
ACWI Index MSCI Ishares | ACWI | Nov 15, 2024 | 118.64 | -0.93 |
Adagene ADR | ADAG | Nov 15, 2024 | 2.16 | -6.90 |
Adagio Medical | ADGM | Nov 15, 2024 | 3.00 | -19.14 |
Adams Diversified Equity Fund | ADX | Nov 15, 2024 | 22.02 | -1.17 |
Adams Natural Resources Fund | PEO | Nov 15, 2024 | 24.20 | -0.33 |
Adams Resources & Energy | AE | Nov 15, 2024 | 37.07 | -0.03 |
AdaptHealth | AHCO | Nov 15, 2024 | 9.64 | -3.98 |
Adaptimmune Therapeutics ADR | ADAP | Nov 15, 2024 | 0.59 | -0.78 |
Adaptive Biotechnologies | ADPT | Nov 15, 2024 | 5.08 | -8.96 |
ADC Therapeutics SA | ADCT | Nov 15, 2024 | 2.39 | -9.81 |
Addentax Group | ATXG | Nov 15, 2024 | 0.62 | -0.24 |
Addex Therapeutics ADR | ADXN | Nov 15, 2024 | 8.06 | -1.71 |
Addus HomeCare | ADUS | Nov 15, 2024 | 119.78 | -1.88 |
Adecoagro | AGRO | Nov 15, 2024 | 11.37 | +5.77 |
Adeia | ADEA | Nov 15, 2024 | 11.60 | -0.60 |
Adial Pharmaceuticals | ADIL | Nov 15, 2024 | 1.06 | -7.02 |
Adicet Bio | ACET | Nov 15, 2024 | 0.95 | -9.82 |
Adient | ADNT | Nov 15, 2024 | 19.89 | -2.50 |
Aditxt | ADTX | Nov 15, 2024 | 0.32 | -7.32 |
Adlai Nortye | ANL | Nov 15, 2024 | 3.12 | -4.59 |
ADMA Biologics | ADMA | Nov 15, 2024 | 19.04 | -5.74 |
Adobe | ADBE | Nov 15, 2024 | 503.37 | -5.00 |
ADS-TEC | ADSE | Nov 15, 2024 | 13.24 | -3.04 |
ADT | ADT | Nov 15, 2024 | 7.49 | 0.00 |
Adtalem Global Education | ATGE | Nov 15, 2024 | 87.20 | +2.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.